Canada’s psychedelic research landscape is shifting fast in 2026, with new clinical trial milestones, policy signals, and commercial production news. Here’s what that means for everyday magic mushroom users, microdosers, and buyers of psilocybin products.
Tag Archives: psilocybin therapy
Psilocybin and LSD are edging closer to FDA approval in the United States — a milestone that could reshape how Canada treats psychedelics. We break down what the news actually says, what it doesn’t, and how it affects Canadian magic mushroom buyers, dispensaries, and delivery services.